Search details
1.
Axillary Nodal Response to Neoadjuvant T-DM1 Combined with Pertuzumab in a Prospective Phase II Multi-Institution Clinical Trial.
J Am Coll Surg
; 238(3): 303-311, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-38047578
2.
Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial.
Nat Commun
; 15(1): 2446, 2024 Mar 19.
Article
in English
| MEDLINE | ID: mdl-38503755
3.
Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical Trial.
J Am Coll Surg
; 237(2): 247-256, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-37194964
4.
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.
Cancer Discov
; 11(10): 2474-2487, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33941592
5.
Pathogen-inspired drug delivery to the central nervous system.
Tissue Barriers
; 2(4): e944449, 2014.
Article
in English
| MEDLINE | ID: mdl-25610755
Results
1 -
5
de 5
1
Next >
>>